Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 191

1.

Transient MOG antibody seroconversion associated with immunomodulating therapy.

Pawlitzki M, Campe C, Rolfes L, Heinze HJ, Leypoldt F, Wandinger KP, Reindl M, Wildemann B, Jarius S, Körtvelyessy P.

Mult Scler Relat Disord. 2020 Jan;37:101420. doi: 10.1016/j.msard.2019.101420. Epub 2019 Sep 28.

PMID:
32172994
2.

Neuromyelitis optica spectrum disorders and pregnancy: therapeutic considerations.

Mao-Draayer Y, Thiel S, Mills EA, Chitnis T, Fabian M, Katz Sand I, Leite MI, Jarius S, Hellwig K.

Nat Rev Neurol. 2020 Mar;16(3):154-170. doi: 10.1038/s41582-020-0313-y. Epub 2020 Feb 20. Review.

PMID:
32080393
3.

Prodromal headache in MOG-antibody positive optic neuritis.

Asseyer S, Hamblin J, Messina S, Mariano R, Siebert N, Everett R, Küker W, Bellmann-Strobl J, Ruprecht K, Jarius S, Leite MI, U Brandt A, Paul F, Palace J.

Mult Scler Relat Disord. 2020 Jan 25;40:101965. doi: 10.1016/j.msard.2020.101965. [Epub ahead of print]

PMID:
32062443
4.

The history of neuromyelitis optica. Part 2: 'Spinal amaurosis', or how it all began.

Jarius S, Wildemann B.

J Neuroinflammation. 2019 Dec 28;16(1):280. doi: 10.1186/s12974-019-1594-1. Review.

5.

Longitudinal optic neuritis-unrelated visual evoked potential changes in NMO spectrum disorders.

Ringelstein M, Harmel J, Zimmermann H, Brandt AU, Paul F, Haarmann A, Buttmann M, Hümmert MW, Trebst C, Schroeder C, Ayzenberg I, Kleiter I, Hellwig K, Havla J, Kümpfel T, Jarius S, Wildemann B, Rommer P, Weber MS, Pellkofer H, Röpke L, Geis C, Retzlaff N, Zettl U, Deppe M, Klotz L, Young K, Stellmann JP, Kaste M, Kermer P, Marouf W, Lauda F, Tumani H, Graf J, Klistorner A, Hartung HP, Aktas O, Albrecht P; Neuromyelitis Optica Study Group (NEMOS).

Neurology. 2020 Jan 28;94(4):e407-e418. doi: 10.1212/WNL.0000000000008684. Epub 2019 Dec 3.

PMID:
31796527
6.

Effects of IVIg treatment on autoantibody testing in neurological patients: marked reduction in sensitivity but reliable specificity.

Grüter T, Ott A, Meyer W, Jarius S, Kinner M, Motte J, Pitarokoili K, Gold R, Komorowski L, Ayzenberg I.

J Neurol. 2020 Mar;267(3):715-720. doi: 10.1007/s00415-019-09614-4. Epub 2019 Nov 14.

PMID:
31728710
7.

Devic's index case: A critical reappraisal - AQP4-IgG-mediated neuromyelitis optica spectrum disorder, or rather MOG encephalomyelitis?

Jarius S, Wildemann B.

J Neurol Sci. 2019 Dec 15;407:116396. doi: 10.1016/j.jns.2019.07.014. Epub 2019 Jul 11.

PMID:
31726278
8.

Optical coherence tomography in myelin-oligodendrocyte-glycoprotein antibody-seropositive patients: a longitudinal study.

Oertel FC, Outteryck O, Knier B, Zimmermann H, Borisow N, Bellmann-Strobl J, Blaschek A, Jarius S, Reindl M, Ruprecht K, Meinl E, Hohlfeld R, Paul F, Brandt AU, Kümpfel T, Havla J.

J Neuroinflammation. 2019 Jul 25;16(1):154. doi: 10.1186/s12974-019-1521-5.

9.

Alemtuzumab in Multiple Sclerosis: Short- and Long-Term Effects of Immunodepletion on the Peripheral Treg Compartment.

Haas J, Würthwein C, Korporal-Kuhnke M, Viehoever A, Jarius S, Ruck T, Pfeuffer S, Meuth SG, Wildemann B.

Front Immunol. 2019 Jun 4;10:1204. doi: 10.3389/fimmu.2019.01204. eCollection 2019.

10.

Cerebrospinal fluid biomarkers for predicting development of multiple sclerosis in acute optic neuritis: a population-based prospective cohort study.

Olesen MN, Soelberg K, Debrabant B, Nilsson AC, Lillevang ST, Grauslund J, Brandslund I, Madsen JS, Paul F, Smith TJ, Jarius S, Asgari N.

J Neuroinflammation. 2019 Mar 11;16(1):59. doi: 10.1186/s12974-019-1440-5.

11.

Leptomeningeal and Intraparenchymal Blood Barrier Disruption in a MOG-IgG-Positive Patient.

Mohseni SH, Skejoe HPB, Wuerfel J, Paul F, Reindl M, Jarius S, Asgari N.

Case Rep Neurol Med. 2018 Dec 9;2018:1365175. doi: 10.1155/2018/1365175. eCollection 2018.

12.
13.

Apheresis therapies for NMOSD attacks: A retrospective study of 207 therapeutic interventions.

Kleiter I, Gahlen A, Borisow N, Fischer K, Wernecke KD, Hellwig K, Pache F, Ruprecht K, Havla J, Kümpfel T, Aktas O, Hartung HP, Ringelstein M, Geis C, Kleinschnitz C, Berthele A, Hemmer B, Angstwurm K, Stellmann JP, Schuster S, Stangel M, Lauda F, Tumani H, Mayer C, Krumbholz M, Zeltner L, Ziemann U, Linker R, Schwab M, Marziniak M, Then Bergh F, Hofstadt-van Oy U, Neuhaus O, Zettl UK, Faiss J, Wildemann B, Paul F, Jarius S, Trebst C; NEMOS (Neuromyelitis Optica Study Group).

Neurol Neuroimmunol Neuroinflamm. 2018 Sep 26;5(6):e504. doi: 10.1212/NXI.0000000000000504. eCollection 2018 Nov.

14.

The first Japanese report on neuromyelitis optica rediscovered: acute bilateral blindness, tetraparesis and respiratory insufficiency in a 35-year-old man (1891).

Jarius S, Wuthenow AB, Wildemann B.

J Neurol Sci. 2018 Dec 15;395:121-125. doi: 10.1016/j.jns.2018.09.005. Epub 2018 Sep 6.

PMID:
30312903
15.

[MOG encephalomyelitis: international recommendations on diagnosis and antibody testing].

Jarius S, Paul F, Aktas O, Asgari N, Dale RC, de Seze J, Franciotta D, Fujihara K, Jacob A, Kim HJ, Kleiter I, Kümpfel T, Levy M, Palace J, Ruprecht K, Saiz A, Trebst C, Weinshenker BG, Wildemann B.

Nervenarzt. 2018 Dec;89(12):1388-1399. doi: 10.1007/s00115-018-0607-0. Review. German.

PMID:
30264269
16.

7 Tesla MRI of Balo's concentric sclerosis versus multiple sclerosis lesions.

Behrens JR, Wanner J, Kuchling J, Ostendorf L, Harms L, Ruprecht K, Niendorf T, Jarius S, Wildemann B, Gieß RM, Scheel M, Bellmann-Strobl J, Wuerfel J, Paul F, Sinnecker T.

Ann Clin Transl Neurol. 2018 Jun 29;5(8):900-912. doi: 10.1002/acn3.572. eCollection 2018 Aug.

17.

Retinal ganglion cell loss in neuromyelitis optica: a longitudinal study.

Oertel FC, Havla J, Roca-Fernández A, Lizak N, Zimmermann H, Motamedi S, Borisow N, White OB, Bellmann-Strobl J, Albrecht P, Ruprecht K, Jarius S, Palace J, Leite MI, Kuempfel T, Paul F, Brandt AU.

J Neurol Neurosurg Psychiatry. 2018 Dec;89(12):1259-1265. doi: 10.1136/jnnp-2018-318382. Epub 2018 Jun 19.

PMID:
29921610
18.

MOG encephalomyelitis: international recommendations on diagnosis and antibody testing.

Jarius S, Paul F, Aktas O, Asgari N, Dale RC, de Seze J, Franciotta D, Fujihara K, Jacob A, Kim HJ, Kleiter I, Kümpfel T, Levy M, Palace J, Ruprecht K, Saiz A, Trebst C, Weinshenker BG, Wildemann B.

J Neuroinflammation. 2018 May 3;15(1):134. doi: 10.1186/s12974-018-1144-2. Review.

19.

MOG-IgG in primary and secondary chronic progressive multiple sclerosis: a multicenter study of 200 patients and review of the literature.

Jarius S, Ruprecht K, Stellmann JP, Huss A, Ayzenberg I, Willing A, Trebst C, Pawlitzki M, Abdelhak A, Grüter T, Leypoldt F, Haas J, Kleiter I, Tumani H, Fechner K, Reindl M, Paul F, Wildemann B.

J Neuroinflammation. 2018 Mar 19;15(1):88. doi: 10.1186/s12974-018-1108-6. Review.

20.

Autoimmune and immunogenetic profile of patients with optic neuritis in a population-based cohort.

Soelberg K, Nilsson AC, Nielsen C, Jarius S, Reindl M, Wildemann B, Lillevang ST, Asgari N.

Mult Scler Relat Disord. 2018 Apr;21:97-102. doi: 10.1016/j.msard.2018.03.003. Epub 2018 Mar 7.

PMID:
29544193
21.

Baló's concentric sclerosis is immunologically distinct from multiple sclerosis: results from retrospective analysis of almost 150 lumbar punctures.

Jarius S, Würthwein C, Behrens JR, Wanner J, Haas J, Paul F, Wildemann B.

J Neuroinflammation. 2018 Jan 18;15(1):22. doi: 10.1186/s12974-017-1043-y.

22.

Magnetic resonance imaging findings at the first episode of acute optic neuritis.

Soelberg K, Skejoe HPB, Grauslund J, Smith TJ, Lillevang ST, Jarius S, Wildemann B, Paul F, Asgari N.

Mult Scler Relat Disord. 2018 Feb;20:30-36. doi: 10.1016/j.msard.2017.12.018. Epub 2017 Dec 25.

PMID:
29291481
23.

Low intrathecal antibody production despite high seroprevalence of Epstein-Barr virus in multiple sclerosis: a review of the literature.

Ruprecht K, Wildemann B, Jarius S.

J Neurol. 2018 Feb;265(2):239-252. doi: 10.1007/s00415-017-8656-z. Epub 2017 Nov 2. Review.

PMID:
29098417
24.

Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patients.

Bouzar M, Daoudi S, Hattab S, Bouzar AA, Deiva K, Wildemann B, Reindl M, Jarius S.

J Neurol Sci. 2017 Oct 15;381:240-244. doi: 10.1016/j.jns.2017.08.3254. Epub 2017 Aug 31.

PMID:
28991690
25.

A population-based prospective study of optic neuritis.

Soelberg K, Jarius S, Skejoe H, Engberg H, Mehlsen JJ, Nilsson AC, Madsen JS, Reindl M, Wildemann B, Grauslund J, Kyvik KO, Smith TJ, Lillevang ST, Paul F, Weinshenker BG, Asgari N.

Mult Scler. 2017 Dec;23(14):1893-1901. doi: 10.1177/1352458517734070. Epub 2017 Oct 5.

PMID:
28980518
26.

Pattern II and pattern III MS are entities distinct from pattern I MS: evidence from cerebrospinal fluid analysis.

Jarius S, König FB, Metz I, Ruprecht K, Paul F, Brück W, Wildemann B.

J Neuroinflammation. 2017 Aug 29;14(1):171. doi: 10.1186/s12974-017-0929-z.

27.

Synapsin-antibodies in psychiatric and neurological disorders: Prevalence and clinical findings.

Höltje M, Mertens R, Schou MB, Saether SG, Kochova E, Jarius S, Prüss H, Komorowski L, Probst C, Paul F, Bellmann-Strobl J, Gitler D, Benfenati F, Piepgras J, Ahnert-Hilger G, Ruprecht K.

Brain Behav Immun. 2017 Nov;66:125-134. doi: 10.1016/j.bbi.2017.07.011. Epub 2017 Jul 18.

PMID:
28733081
28.

Devic's disease before Devic: On the contribution of Friedrich Albin Schanz (1863-1923).

Jarius S, Wildemann B.

J Neurol Sci. 2017 Aug 15;379:99-102. doi: 10.1016/j.jns.2017.05.044. Epub 2017 May 23.

PMID:
28716289
29.

Identification of the flotillin-1/2 heterocomplex as a target of autoantibodies in bona fide multiple sclerosis.

Hahn S, Trendelenburg G, Scharf M, Denno Y, Brakopp S, Teegen B, Probst C, Wandinger KP, Buttmann M, Haarmann A, Szabados F, Vom Dahl M, Kümpfel T, Eichhorn P, Gold H, Paul F, Jarius S, Melzer N, Stöcker W, Komorowski L.

J Neuroinflammation. 2017 Jun 23;14(1):123. doi: 10.1186/s12974-017-0900-z.

30.

Aquaporin-4 antibodies in patients treated with natalizumab for suspected MS.

Gahlen A, Trampe AK, Haupeltshofer S, Ringelstein M, Aktas O, Berthele A, Wildemann B, Gold R, Jarius S, Kleiter I.

Neurol Neuroimmunol Neuroinflamm. 2017 Jun 16;4(4):e363. doi: 10.1212/NXI.0000000000000363. eCollection 2017 Jul.

31.

From dizziness to severe ataxia and dysarthria: New cases of anti-Ca/ARHGAP26 autoantibody-associated cerebellar ataxia suggest a broad clinical spectrum.

Wallwitz U, Brock S, Schunck A, Wildemann B, Jarius S, Hoffmann F.

J Neuroimmunol. 2017 Aug 15;309:77-81. doi: 10.1016/j.jneuroim.2017.05.011. Epub 2017 May 22.

PMID:
28601293
32.

Failure of alemtuzumab therapy to control MOG encephalomyelitis.

Wildemann B, Jarius S, Schwarz A, Diem R, Viehöver A, Hähnel S, Reindl M, Korporal-Kuhnke M.

Neurology. 2017 Jul 11;89(2):207-209. doi: 10.1212/WNL.0000000000004087. Epub 2017 Jun 9. No abstract available.

PMID:
28600462
33.

Immunotherapies in neuromyelitis optica spectrum disorder: efficacy and predictors of response.

Stellmann JP, Krumbholz M, Friede T, Gahlen A, Borisow N, Fischer K, Hellwig K, Pache F, Ruprecht K, Havla J, Kümpfel T, Aktas O, Hartung HP, Ringelstein M, Geis C, Kleinschnitz C, Berthele A, Hemmer B, Angstwurm K, Young KL, Schuster S, Stangel M, Lauda F, Tumani H, Mayer C, Zeltner L, Ziemann U, Linker RA, Schwab M, Marziniak M, Then Bergh F, Hofstadt-van Oy U, Neuhaus O, Zettl U, Faiss J, Wildemann B, Paul F, Jarius S, Trebst C, Kleiter I; NEMOS (Neuromyelitis Optica Study Group).

J Neurol Neurosurg Psychiatry. 2017 Aug;88(8):639-647. doi: 10.1136/jnnp-2017-315603. Epub 2017 Jun 1.

34.

Pavlov's Reflex before Pavlov: Early Accounts from the English, French and German Classic Literature.

Jarius S, Wildemann B.

Eur Neurol. 2017;77(5-6):322-326. doi: 10.1159/000475811. Epub 2017 May 25.

35.

[Neuromyelitis optica].

Pache F, Wildemann B, Paul F, Jarius S.

Fortschr Neurol Psychiatr. 2017 Feb;85(2):e1. doi: 10.1055/s-0035-1567186. Epub 2017 Apr 5. German. No abstract available.

PMID:
28380640
36.

Aquaporin-4-autoimmunity in patients with systemic lupus erythematosus: A predominantly population-based study.

Asgari N, Jarius S, Laustrup H, Skejoe HP, Lillevang ST, Weinshenker BG, Voss A.

Mult Scler. 2018 Mar;24(3):331-339. doi: 10.1177/1352458517699791. Epub 2017 Mar 22.

PMID:
28326889
37.

Alzheimer's disease: Elevated pigment epithelium-derived factor in the cerebrospinal fluid is mostly of systemic origin.

Lang V, Zille M, Infante-Duarte C, Jarius S, Jahn H, Paul F, Ruprecht K, Pina AL.

J Neurol Sci. 2017 Apr 15;375:123-128. doi: 10.1016/j.jns.2017.01.051. Epub 2017 Jan 17.

PMID:
28320113
38.

Myelin oligodendrocyte glycoprotein antibodies: How clinically useful are they?

Reindl M, Jarius S, Rostasy K, Berger T.

Curr Opin Neurol. 2017 Jun;30(3):295-301. doi: 10.1097/WCO.0000000000000446. Review.

PMID:
28248700
39.

[Neuromyelitis optica].

Pache F, Wildemann B, Paul F, Jarius S.

Fortschr Neurol Psychiatr. 2017 Feb;85(2):100-114. doi: 10.1055/s-0042-124186. Epub 2017 Feb 24. Review. German.

PMID:
28235212
40.

Diagnostic criteria for Susac syndrome.

Kleffner I, Dörr J, Ringelstein M, Gross CC, Böckenfeld Y, Schwindt W, Sundermann B, Lohmann H, Wersching H, Promesberger J, von Königsmarck N, Alex A, Guthoff R, Frijns CJ, Kappelle LJ, Jarius S, Wildemann B, Aktas O, Paul F, Wiendl H, Duning T; European Susac Consortium (EuSaC).

J Neurol Neurosurg Psychiatry. 2016 Dec;87(12):1287-1295. doi: 10.1136/jnnp-2016-314295. Epub 2016 Oct 25. Review.

PMID:
28103199
41.

B-cell populations discriminate between pediatric- and adult-onset multiple sclerosis.

Schwarz A, Balint B, Korporal-Kuhnke M, Jarius S, von Engelhardt K, Fürwentsches A, Bussmann C, Ebinger F, Wildemann B, Haas J.

Neurol Neuroimmunol Neuroinflamm. 2016 Dec 15;4(1):e309. doi: 10.1212/NXI.0000000000000309. eCollection 2017 Jan.

42.

The MRZ reaction as a highly specific marker of multiple sclerosis: re-evaluation and structured review of the literature.

Jarius S, Eichhorn P, Franciotta D, Petereit HF, Akman-Demir G, Wick M, Wildemann B.

J Neurol. 2017 Mar;264(3):453-466. doi: 10.1007/s00415-016-8360-4. Epub 2016 Dec 22. Review.

PMID:
28005176
43.

[Autoantibody-associated autoimmune encephalitis and cerebellitis : Clinical presentation, diagnostic work-up and treatment].

Lewerenz J, Jarius S, Wildemann B, Wandinger KP, Leypoldt F.

Nervenarzt. 2016 Dec;87(12):1293-1299. Review. German.

PMID:
27847964
44.

Myeloid dendritic cells exhibit defects in activation and function in patients with multiple sclerosis.

Haas J, Schwarz A, Korporal-Kuhnke M, Jarius S, Wildemann B.

J Neuroimmunol. 2016 Dec 15;301:53-60. doi: 10.1016/j.jneuroim.2016.10.007. Epub 2016 Nov 2.

PMID:
27836182
45.

MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcome.

Jarius S, Kleiter I, Ruprecht K, Asgari N, Pitarokoili K, Borisow N, Hümmert MW, Trebst C, Pache F, Winkelmann A, Beume LA, Ringelstein M, Stich O, Aktas O, Korporal-Kuhnke M, Schwarz A, Lukas C, Haas J, Fechner K, Buttmann M, Bellmann-Strobl J, Zimmermann H, Brandt AU, Franciotta D, Schanda K, Paul F, Reindl M, Wildemann B; in cooperation with the Neuromyelitis Optica Study Group (NEMOS).

J Neuroinflammation. 2016 Nov 1;13(1):281.

46.

MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 4: Afferent visual system damage after optic neuritis in MOG-IgG-seropositive versus AQP4-IgG-seropositive patients.

Pache F, Zimmermann H, Mikolajczak J, Schumacher S, Lacheta A, Oertel FC, Bellmann-Strobl J, Jarius S, Wildemann B, Reindl M, Waldman A, Soelberg K, Asgari N, Ringelstein M, Aktas O, Gross N, Buttmann M, Ach T, Ruprecht K, Paul F, Brandt AU; in cooperation with the Neuromyelitis Optica Study Group (NEMOS).

J Neuroinflammation. 2016 Nov 1;13(1):282.

47.

MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.

Jarius S, Ruprecht K, Kleiter I, Borisow N, Asgari N, Pitarokoili K, Pache F, Stich O, Beume LA, Hümmert MW, Ringelstein M, Trebst C, Winkelmann A, Schwarz A, Buttmann M, Zimmermann H, Kuchling J, Franciotta D, Capobianco M, Siebert E, Lukas C, Korporal-Kuhnke M, Haas J, Fechner K, Brandt AU, Schanda K, Aktas O, Paul F, Reindl M, Wildemann B; in cooperation with the Neuromyelitis Optica Study Group (NEMOS).

J Neuroinflammation. 2016 Sep 27;13(1):280.

48.

MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin.

Jarius S, Ruprecht K, Kleiter I, Borisow N, Asgari N, Pitarokoili K, Pache F, Stich O, Beume LA, Hümmert MW, Trebst C, Ringelstein M, Aktas O, Winkelmann A, Buttmann M, Schwarz A, Zimmermann H, Brandt AU, Franciotta D, Capobianco M, Kuchling J, Haas J, Korporal-Kuhnke M, Lillevang ST, Fechner K, Schanda K, Paul F, Wildemann B, Reindl M; in cooperation with the Neuromyelitis Optica Study Group (NEMOS).

J Neuroinflammation. 2016 Sep 26;13(1):279.

49.

Inositol 1,4,5-trisphosphate receptor type 1 autoantibodies in paraneoplastic and non-paraneoplastic peripheral neuropathy.

Jarius S, Ringelstein M, Haas J, Serysheva II, Komorowski L, Fechner K, Wandinger KP, Albrecht P, Hefter H, Moser A, Neuen-Jacob E, Hartung HP, Wildemann B, Aktas O.

J Neuroinflammation. 2016 Oct 24;13(1):278.

50.

Influence of female sex and fertile age on neuromyelitis optica spectrum disorders.

Borisow N, Kleiter I, Gahlen A, Fischer K, Wernecke KD, Pache F, Ruprecht K, Havla J, Krumbholz M, Kümpfel T, Aktas O, Ringelstein M, Geis C, Kleinschnitz C, Berthele A, Hemmer B, Angstwurm K, Weissert R, Stellmann JP, Schuster S, Stangel M, Lauda F, Tumani H, Mayer C, Zeltner L, Ziemann U, Linker RA, Schwab M, Marziniak M, Then Bergh F, Hofstadt-van Oy U, Neuhaus O, Winkelmann A, Marouf W, Rückriem L, Faiss J, Wildemann B, Paul F, Jarius S, Trebst C, Hellwig K; NEMOS (Neuromyelitis Optica Study Group).

Mult Scler. 2017 Jul;23(8):1092-1103. doi: 10.1177/1352458516671203. Epub 2016 Oct 6.

PMID:
27758954

Supplemental Content

Loading ...
Support Center